Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
AB Sciex
Bio-Rad Diabetes Division

Autoantibody Targets Identified in Lupus Patients

By Labmedica International staff writers
Posted on 09 Dec 2013
Image: Blood smear showing an “LE cell” from a patient with systemic lupus erythematosus (Photo courtesy of Imperial College London).
Image: Blood smear showing an “LE cell” from a patient with systemic lupus erythematosus (Photo courtesy of Imperial College London).
Patients with the autoimmune disease systemic lupus erythematosus (SLE) produce autoantibodies that can cause damage to multiple organ systems.

A microarray has been developed to identify cytokines, chemokines, and other circulating proteins as potential targets of the autoantibodies produced by SLE patients, and are implicated in inflammatory autoimmune disease and diseases of immune deficiency.

Scientists at Stanford University (CA, USA) and their colleagues from other institutes designed a nitrocellulose-surface microarray containing human cytokines, chemokines, and other circulating proteins and demonstrated that the array permitted specific detection of serum factor-binding probes. They used antibody binding assays and an indirect B cell-activating factor (BAFF) enzyme-linked immunoassay to detect autoantibodies.

Serum profiling from individuals with SLE revealed that among several targets, elevated immunoglobulin G (IgG) autoantibody reactivity to BAFF was associated with SLE compared with control samples. BAFF reactivity correlated with the severity of disease-associated features, including interferon (IFN)-α–driven SLE pathology. Of the other novel targets of autoantibodies they identified, the observed reactivity to the growth factors epidermal growth factor, (EGF), and somatotropin (HGH) were of particular interest.

Further screening of samples derived from individuals with SLE and other inflammatory autoimmune diseases revealed striking array reactivity to these and other growth factor targets, including various isoforms of fibroblast growth factor (FGF). The idea of an inverse relationship between inflammation- and growth factor-mediated pathways is an area of increasing interest in the field of inflammation.

The authors concluded that the implication of growth factor-targeted autoantibodies in the potential trade-off between tissue growth/repair and inflammation is one intriguing avenue to pursue. That serum factor-protein microarrays facilitated the detection of autoantibody reactivity to serum factors in human samples and that BAFF-reactive autoantibodies may be associated with an elevated inflammatory disease state within the spectrum of SLE. The study was published on November 25, 2013, in the Journal of Clinical Investigation.

Related Links:

Stanford University



77 ELEKTRONIKA
PURITAN MEDICAL
DiagCor Bioscience
comments powered by Disqus
Sekisui Diagnostics

Channels

Clinical Chemistry

view channel
Image: The Cobas 6000 Multipurpose Clinical Laboratory analyzer (Photo courtesy of Roche Diagnostics).

Low Density Lipoprotein Apolipoprotein-B Assay Validated

The relationship between apolipoprotein-B (Apo-B) concentration and the risk of developing cardiovascular disease (CVD) is more robust than the relationship between low density lipoprotein cholesterol... Read more

Genetic Tests

view channel
Histopathology of colonic adenocarcinoma; the glands are enlarged and filled with necrotic debris (Photo courtesy of the University of Utah).

Promising Blood Biomarkers Isolated for Colorectal Cancer

The search for blood-borne biomarkers that could be used to screen for colorectal cancer (CRC) has uncovered two promising candidates that may one day lead to the development of a simple blood test.... Read more

Microbiology

view channel

Novel Sequence Analysis Services Improve Pathogen Identification

A set of new-generation sequencing (NGS) services provides unique tools for more effective identification of known and unknown microorganisms, including bacterial, viral, fungal, and protozoan parasite pathogens. Aperiomics (Ashburn, VA, USA) has now introduced its breakthrough Absolute-NGS Pathogen Detection Platform... Read more

Industry News

view channel

Market for qPCR Exceeds USD 3 Billion

The market for real-time quantitative polymerase chain reaction (qPCR) was valued at about USD 3.2 billion for 2013 according to Kalorama Information (New York, NY, USA) an increase from USD 2.8 billion in 2011. The healthcare market researcher said that the testing system is considered the workhorse of research providing... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.